Current Ratio of CNS Pharmaceuticals, Inc. from 30 Jun 2020 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
CNS Pharmaceuticals, Inc. quarterly Current Ratio in % history and change rate from 30 Jun 2020 to 30 Sep 2025.
  • CNS Pharmaceuticals, Inc. Current Ratio for the quarter ending 30 Sep 2025 was 554%, a 903% increase year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Change (%)

CNS Pharmaceuticals, Inc. Quarterly Current Ratio (%)

Period Value YoY Chg Change % Date
Q3 2025 554% +499% +903% 30 Sep 2025
Q2 2025 409% +377% +1173% 30 Jun 2025
Q1 2025 198% +142% +255% 31 Mar 2025
Q4 2024 102% +9.7% +11% 31 Dec 2024
Q3 2024 55% -108% -66% 30 Sep 2024
Q2 2024 32% -211% -87% 30 Jun 2024
Q1 2024 56% -304% -84% 31 Mar 2024
Q4 2023 92% -489% -84% 31 Dec 2023
Q3 2023 164% -562% -77% 30 Sep 2023
Q2 2023 244% -396% -62% 30 Jun 2023
Q1 2023 360% -238% -40% 31 Mar 2023
Q4 2022 581% +62% +12% 31 Dec 2022
Q3 2022 726% +63% +9.5% 30 Sep 2022
Q2 2022 640% -87% -12% 30 Jun 2022
Q1 2022 598% -161% -21% 31 Mar 2022
Q4 2021 519% -416% -44% 31 Dec 2021
Q3 2021 663% -786% -54% 30 Sep 2021
Q2 2021 727% -116% -14% 30 Jun 2021
Q1 2021 759% 31 Mar 2021
Q4 2020 934% 31 Dec 2020
Q3 2020 1448% 30 Sep 2020
Q2 2020 842% 30 Jun 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.